发明申请
US20100068231A1 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent
有权
至少一种肉毒杆菌神经毒素治疗由至少一种抗肿瘤剂诱导的疼痛的治疗用途
- 专利标题： Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent
- 专利标题（中）： 至少一种肉毒杆菌神经毒素治疗由至少一种抗肿瘤剂诱导的疼痛的治疗用途
-
申请号： US12447443申请日： 2007-10-26
-
公开(公告)号： US20100068231A1公开(公告)日： 2010-03-18
- 发明人: Christine Favre , Michel Auguet , Pierrre-Etienne Chabrier De Lassauniere
- 申请人： Christine Favre , Michel Auguet , Pierrre-Etienne Chabrier De Lassauniere
- 优先权： FR0609435 20061027
- 国际申请： PCT/FR07/01773 WO 20071026
- 主分类号： A61K39/08
- IPC分类号： A61K39/08 ; A61P25/00
摘要：
The present invention relates to a method of treating or preventing pain or pains induced by an anti-neoplastic agent, comprising the step of administering an effective amount of at least one botulinum neurotoxin to a patient in need thereof.
公开/授权文献
信息查询
